Russ Swan, Editor, writes:
We see from your search that you're looking for information on the term "Infectious Diseases",
and we have a large number of manufacturers' news releases and technical articles here on Laboratorytalk which will be of interest.
Let me be your guide.
Start with
the news release Manufacturing agreement for TNFerade from
Cobra Biomanufacturing, which we summarised at the time by saying "Cobra Biomanufacturing has entered into a manufacturing development agreement with GenVec for TNFerade, GenVec's lead product candidate".
Earlier in the week,
we featured the news release Expanding the boundaries of mass spectrometry from
Waters: "Waters has launched its Synapt MS system, describing it as a next-generation quadrupole orthogonal acceleration, time-of-flight (oa-Tof) mass spectrometry (MS) platform".
In January 2008, we covered the news from Franek Technologies
- take a look at Security and biofuels behind rapid sales growth
which says: "Purpose-built power protection systems safeguarding the USA's labs and protecting latest biofuel production research for oil independence".
Take a look also at the news release from Waters, Pushing the limits of infectious disease research,
as well as Automation boosts monoclonal antibody production from Beckman Coulter,
and Pan-European collaboration for hepatitis test from Farfield Scientific.
See also:
The past, present, and future of DNA analysis
(October 2007)
Pplied Biosystems says it is continuing its leadership in DNA sequencing by commercialising products that provide total solutions for researchers from discovery through validation and screening
Efficient method of sequencing ancient DNA
(October 2007)
Researchers from Pennsylvania State University have used 454 Life Sciences's Genome Sequencer system to sequencing the entire mitochondrial genomes from ten individual woolly mammoths
Structural variation plays role in genetics
(September 2007)
454 Life Sciences, with Yale University researchers, has developed a method using the Genome Sequencer system to identify significant human genetic variability with an unprecedented level of detail
First LNA-based in vitro diagnostic for superbugs
(September 2007)
VanA/B Evigene is the first Locked nucleci acid (LNA)-based in vitro diagnostic test for vancomycin-resistant enterococci (VRE) and vancomycin-resistant staphylococcus aureus (VRSA)
Honeybee virus found through sequencing technology
(September 2007)
Researchers at Columbia University have identified a virus implicated in the deaths of 2.4million honeybee colonies - tens of billions of bees - using 454 Life Sciences's Genome Sequencer system
First academic course in high content screening
(August 2007)
The school of medicine at Trinity College Dublin, Ireland, has launched what it claims is the world's first academic course in high content screening and analysis
BioAnalyte gives support to Ipex mass spectrometry
(June 2007)
BioAnalyte says that it supports the intact protein expression (Ipex) mass spectrometry methods developed by the US FDA Center for Food Safety and Applied Nutrition (CFSAN)
Diagnostic technology reduces mortality
(May 2007)
Major study by Washington Hospital's infectious disease specialists shows AdvanDx's PNA Fish significantly reduces mortality associated with staphylococcus aureus bloodstream infections in the ICU
Haptogen nominated 'rising star' in life sciences
(March 2007)
Company proved once again the success of its current business model based on generating revenue through leveraging its technology and expertise in antibody generation
Oxford Biomedica to acquire Oxxon Therapeutics
(March 2007)
Acquisition of privately held biotechnology company, based in Oxford, UK, adds melanoma cancer vaccine and extends immunotherapy platform
Mals instruments characterise malaria candidates
(March 2007)
Multi-angle light scattering (Mals) instruments were found to facilitate understanding of purity, identity and aggregation states of recombinant protein vaccine candidates separated by SEC
Avian transgenics: Interferon Alpha in eggs
(January 2007)
Oxford BioMedica, Viragen , and Roslin Institute, announce the successful expression of human interferon alpha-2a in the whites of eggs laid by transgenic hens using the Ova system
Pharmacogenetic services for Schering-Plough
(January 2007)
Warnex announces that its medical laboratories division will develop new pharmacogenetic assays and serve as a central laboratory for several clinical studies of Schering-Plough Canada
Infectious diseases provide compelling meeting
(November 2006)
Emerging and Drug-Resistant Infectious Diseases drew participants from across the UK and Europe to explore the challenges and opportunities of drug discovery, vaccines, prophylactics and therapeutics
Three finalists named for Biotechnica Award 2006
(September 2006)
International jury has nominated biotechnology companies Amaxa from Germany, Intercell from Austria, and Genmab from Denmark for the award, which is worth a total of 40,000 euros in prize money
Exclusive access to antibody technology
(August 2006)
Oxford BioMedica signed an agreement in February 2001 with the French Centre for National Scientific Research and the University of Montpellier that grants exclusive access to antibody technology
Agreement covers Ibis T5000 biosensor system
(August 2006)
Ibis T5000 is a universal biosensor that can simultaneously identify thousands of types of infectious organisms in a sample, without needing to know beforehand what might be present in the sample
Clinical trial of DNA-based H5N1 (avian) vaccine
(July 2006)
PowderMed has submitted regulatory documentation to the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for permission to conduct a clinical trial to test its H5N1 avian flu vaccine
Phase II results with Trovax are 'encouraging'
(June 2006)
Oxford BioMedica, a gene therapy company, reported that encouraging data from five Phase II studies of Trovax, its lead cancer immunotherapy product, were presented at the annual meeting of Asco
Air quality control lamps kill micro-organisms
(June 2006)
Lamps work within existing heating and air-conditioning systems to kill both surface and airborne micro-organisms including a significant percentage of H5N1 avian flu viruses, legionella, and bacteria
New range of antibodies and expression systems
(May 2006)
Cambridge BioScience has been named new distributor for Imgenex products in the UK and Ireland
Warnex to buy Pro-DNA Diagnostic Laboratory
(April 2006)
Warnex has entered into an agreement in principle for the acquisition of Pro-DNA Diagnostic, a laboratory offering genetic testing services
Leak-free connections speed endoscope reprocessing
(April 2006)
Today's medical practitioners rely on flexible endoscopes for a variety of diagnoses ranging from those involving colon-related illnesses to sinus ailments
Sartorius and ProMetic announce two agreements
(April 2006)
Collaboration for improved separation systems for plasma proteins, and agreement to combine membrane and ligand technologies for expanded product offerings
Syft scores early success at Christchurch Hospital
(April 2006)
Within months of installing Syft Technologies's LDI-2 research instrument, scientists are already achieving significant progress toward the speedy, breath-based diagnosis of life-threatening diseases
Copper touch surfaces in healthcare facilities
(March 2006)
Research demonstrates rapid antimicrobial activity of copper against MRSA with 99.9% inactivation in 90 minutes
Analysis of polymicrobial infections in patients
(March 2006)
Simultaneous analysis of DNA from multiple bacterial species present in a single specimen observed in transplant patients offers opportunity to address new markets
How vaccines can prevent cancer
(March 2006)
Vaccines against specific viruses could prevent one in ten cases of cancer in Britain, according to a new report by Cancer Research UK
Cobra in gene therapy deal with Replikun Biotech
(March 2006)
Cobra Biomanufacturing has signed a contract with the Australian company Replikun Biotech to support the development of an innovative gene therapy method
Analytica 2006 accelerates laboratory processes
(March 2006)
Together with the Analytica Conference, Analytica 2006 is more than just a platform for gathering comprehensive, in-depth information on the latest techniques, it is also a forum of best practices
Sensing system looks for Sars and avian flu
(February 2006)
With a high efficiency for inspection of fever-symptom caused by Sars or avian flu the camera is ideal for train stations, airports, supermarkets, ports, hotels and other places with flowing crowds
Scientific standards for Middle East biotech park
(February 2006)
Dubai Biotechnology and Research Park choses RTI International to develop scientific and regulatory standards that will be used to advance biotechnology research and development across the Middle East
Acquisition of point-of-care cardiac diagnostics
(February 2006)
Cardiac Status line includes four FDA-cleared tests that can be used at the point-of-care to determine elevations of cardiac markers, diagnose acute coronary syndrome (ACS) as indicated by chest pain
Aaron Geist appointed VP business development
(January 2006)
Geist will be responsible for developing PerkinElmer's strategic partnerships and acquisition opportunities